Argenica Therapeutics Options Expire Unexercised
Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Limited announced the cessation of 600,000 options due to their expiry on June 10, 2024, without being exercised or converted. This financial update is relevant for investors tracking changes in the company’s issued capital.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.